Concepedia

Thomas J. Baric

TJ

Statistics

Publications

9

Citations

293

H-Index

9

Active since

2018

Affiliations

University of North Carolina at Chapel Hill(Current)

Yale University

UNC Lineberger Comprehensive Cancer Center

University of North Carolina Health Care

Johns Hopkins University

Thomas J. Baric is an author at University of North Carolina at Chapel Hill specializing in virology, life sciences, and molecular virology.

ORCID

Publications per year

2018–2024

9

Publications

9

Genetic Variation between Dengue Virus Type 4 Strains Impacts Human Antibody Binding and Neutralization

Emily N. Gallichotte, Thomas J. Baric, Usha K. Nivarthi et al. · Cell Reports · 2018 · 75 citations · Full text

, , +17

Human dengue virus serotype 2 neutralizing antibodies target two distinct quaternary epitopes

Emily N. Gallichotte, Thomas J. Baric, Boyd L. Yount et al. · PLoS Pathogens · 2018 · 49 citations · Full text

, , +17

Identification of Dengue Virus Serotype 3 Specific Antigenic Sites Targeted by Neutralizing Human Antibodies

Ellen Young, Robert H. Carnahan, Daniela V. Andrade et al. · Cell Host & Microbe · 2020 · 48 citations · Full text

, , +15

Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies

Emily N. Gallichotte, Ellen Young, Thomas J. Baric et al. · mBio · 2019 · 42 citations · Full text

, , +17

The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses

David R. Martinez, Fernando R. Moreira, Nicholas Catanzaro et al. · Science Translational Medicine · 2024 · 21 citations · Full text

, , +17

1–5 of 9